Cerebrolysin 60mg
Cerebrolysin 60mg · Result: Content quantification (Janoshik) · Report Code: 1NSTIVUTWSXK · Test Date: 2026-08-06 · Lab: Janoshik Analytical
View independent report #212145 ↗Cyclic and Neuropeptide Research Compounds SKU: CP-CBL60
Cerebrolysin 60mg
♢ Research use only Specifikacija klase; odabrane serije testira Janoshik
Analiza sadržaja Content quantification (Janoshik)Cerebrolysin 60mg · Report #212145 ↗€28.99
Free standard EU shipping on orders over €200
If a product doesn't match the specification on its published COA, contact us with your batch number: we investigate against the lot's report and replace any product that fails it, at no cost to you.
Contact us within 48 hours of delivery with photos of the outer box, inner packing, and any affected vials with labels legible. Confirmed transit damage is replaced at no cost to you.
Returns policy →Shipping estimate for EU
3–7 days most of the EU · 10–14 Nordics/Baltics. Dispatched within 1–2 business days. Check destination rates at checkout.
Full shipping informationCerebrolysin istraživačke kvalitete. Evidentirana specifikacija: peptidni hidrolizat (ekstrakt svinjskog mozga), ≥85% peptida ≤10 kDa; odabrane serije neovisno testirane. Liofilizirani prah u zatvorenoj staklenoj bočici. Samo u istraživačke svrhe. Nije za ljudsku potrošnju.
O proizvodu Cerebrolysin 60mg
Cerebrolysin is a multi-peptide brain-derived neurotrophic preparation consisting of enzymatically treated porcine brain protein. The preparation contains a mixture of low-molecular-weight neuropeptides and free amino acids that cross the blood-brain barrier. It has an unusually long history for a peptide complex and has been studied in the context of neurological injury models including ischemic, traumatic, and vascular insults — and has been characterised since the 1970s. Each vial contains 60mg of the lyophilized preparation.
The active components of Cerebrolysin are not fully defined chemically, which distinguishes it from single-compound neurotrophic peptides. The preparation has demonstrated neurotrophic factor-like activity in cell culture and animal models: it promotes neuronal survival, enhances synaptic plasticity, stimulates neurogenesis, and exhibits neuroprotective effects in various injury models. Preclinical and in-vitro studies have examined its effects on recovery and cognitive parameters in injury and neurodegeneration models, with variable results across study designs. The European Medicines Agency has characterised it within some neurological research contexts.
For research purposes, Cerebrolysin is a useful tool for studying multi-factor neurotrophic support — where the combined effect of multiple small peptides may recapitulate some of the biological activity of endogenous neurotrophic factors (BDNF, NGF, GDNF) more completely than any single defined compound.
Specifications
| Parameter | Value |
|---|---|
| Compound | Cerebrolysin (porcine brain-derived neuropeptide complex) |
| Amount per Vial | 60mg lyophilized |
| Composition | Low-MW neuropeptides + free amino acids from porcine brain proteins |
| Format | Lyophilized powder |
| Reconstitution | Sterile water or saline |
| Čuvanje | 2-8°C |
Čuvanje
Store at 2-8°C (refrigerator) as lyophilized powder. Refrigerate after reconstitution. As a biological preparation, avoid freezing and thawing cycles.
What makes Cerebrolysin different from a single neurotrophic peptide?
Single neurotrophic peptides (like BDNF or NGF) target specific receptors. Cerebrolysin contains a mixture of multiple small peptides and amino acids that together mimic aspects of the brain’s complex neurotrophic environment. In research, this can be advantageous when the goal is broad neuroprotection or neurogenesis stimulation rather than receptor-specific pharmacology. The trade-off is that the mixture composition is not fully defined, which limits mechanistic interpretation. Cerebrolysin is better suited for studies where the preparation itself is the research focus, or for generating hypotheses that can then be pursued with defined single compounds.
How does Cerebrolysin penetrate the blood-brain barrier?
Cerebrolysin’s active components are specifically the low-molecular-weight fraction (peptides under approximately 10 kDa) — the preparation is enzymatically processed to ensure these small peptides predominate. Small peptides can cross the blood-brain barrier through passive diffusion (if sufficiently lipophilic), transcytosis, or active transport. The preparation is documented to produce measurable CNS effects after systemic IV or IM administration in preclinical models, indicating at least partial CNS delivery. The full pharmacokinetics of the mixed preparation are complex to characterize precisely.
What are the main research areas for Cerebrolysin?
The most-studied research area for Cerebrolysin is ischemic injury models — preclinical work has examined neurological outcome parameters when administered early in models of ischemic insult. Neurodegeneration models have examined cognitive parameters in some studies but not consistently across designs. Traumatic injury models have been another focus, with preclinical data examining neuroprotection. The research base is heterogeneous in quality, and the compound is characterised differently across regulatory jurisdictions.
Cerebrolysin is supplied for research purposes only. Not for human consumption. Handle in compliance with institutional biosafety guidelines.
| Parametar | Vrijednost |
|---|---|
| Spoj | Cerebrolysin (kompleks neuropeptida dobiven iz svinjskog mozga) |
| Količina po bočici | 60mg liofilizirano |
| Sastav | Niskomolekularni neuropeptidi + slobodne aminokiseline iz svinjskih moždanih proteina |
| Oblik | Liofilizirani prah |
| Rekonstitucija | Sterilna voda ili fiziološka otopina |
| Čuvanje | 2-8°C |
Follow the storage conditions on the product label and its published documentation. Handle only in an appropriately equipped laboratory.
Peptide Reconstitution Calculator →Povjerenje istraživača
Zašto istraživači biraju CertaPeptides
Tko zapravo testira ovo?
Odabrane serije neovisno provjerava Janoshik Analytical (Češka) i objavljuju se na javnom portalu Janoshik. Ostale serije otpremaju se sa specifikacijom serije dobavljača. Objavljeni pregled pogledajte na /coa.
Pogledaj COA →Što ako dobijem pogrešnu seriju?
Svaka naljepnica bočice nosi kod. Potražite ga na našoj stranici za provjeru: ona prikazuje ono što CertaPeptides objavljuje za taj kod, a za povučenu seriju i to da je serija povučena te zašto. Ako je vaša serija povučena ili ako pretraga koda s vaše naljepnice ne pronađe ništa, pošaljite nam taj kod e-poštom.
Pogledaj COA →Odakle se otprema?
Rumunjska (EU). Mi smo CERTALAB SRL, CUI 54169956, registrirani za PDV. Sameday za Rumunjsku, GLS za većinu odredišta u EU-u, TCE Worldwide za ostala prekogranična tržišta EU-a i izvan EU-a (Ujedinjeno Kraljevstvo, Švicarska). Dostava 1–15 radnih dana ovisno o odredištu — točan rok prikazan je na blagajni.
Detalji dostave →Što ako se pojavi problem?
Imate pravo na odustajanje u roku od 14 dana prema OUG 34/2014 (rumunjski/EU propisi o zaštiti potrošača), uz mogućnost eskalacije prema ANPC-u i alternativnog rješavanja sporova (SAL). Kontaktirajte nas na support@chinapeptideshop.com.
Pravila o povratu →Informacije o proizvodu
Ovaj je proizvod namijenjen isključivo za znanstvena istraživanja i razvoj. Riječ je o kemijskoj tvari koja se ne smije upotrebljavati kao lijek, medicinski pripravak, djelatna tvar ni sastojak u bilo kojem proizvodu namijenjenom ljudskoj ili životinjskoj potrošnji. Istraživači moraju s ovim spojem rukovati u skladu sa smjernicama biološke sigurnosti svoje ustanove. Upotrebljavajte ga isključivo u primjereno opremljenim laboratorijskim uvjetima uz odgovarajuću osobnu zaštitnu opremu.
Peptidi u liofiliziranom (sušenom smrzavanjem) obliku otpremaju se u zatvorenim staklenim bočicama standardnim metodama dostave i ne zahtijevaju hlađenje tijekom transporta. Liofilizirani peptidi vrlo su stabilni na sobnoj temperaturi tijekom trajanja standardne dostave (uobičajeni rokovi transporta prikazani su na blagajni). Nakon primitka proizvod odmah prenesite na rashlađeno čuvanje (2–8°C).
Često postavljana pitanja
Istraživački peptidi isporučuju se u liofiliziranom (sušenom smrzavanjem) obliku. Količina materijala obično iznosi tek nekoliko miligrama — pojavljuje se kao vrlo tanak film ili mala peleta na dnu bočice, često gotovo nevidljiva. To je posve normalno.
Za razliku od nekih dobavljača koji dodaju punila u rasutom stanju (poput manitola), CertaPeptides isporučuje čisti peptid bez nepotrebnih dodataka.
Knjižnica istraživanja
Povezani istraživački članci
Frequently researched together
Cerebrolysin 60mg
Retatrutide
SS-31
NAD+Combined Price €157.46
View All Products